학술논문

Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia
Document Type
article
Source
The Pediatric Infectious Disease Journal. 36(1)
Subject
Paediatrics
Biomedical and Clinical Sciences
Atherosclerosis
Prevention
Clinical Research
Pediatric
HIV/AIDS
Infectious Diseases
Cardiovascular
Evaluation of treatments and therapeutic interventions
6.1 Pharmaceuticals
Good Health and Well Being
Adolescent
Adult
Anti-HIV Agents
Atorvastatin
C-Reactive Protein
Child
Female
HIV Infections
Humans
Hyperlipidemias
Male
Young Adult
HIV
children
atorvastatin
P1063 Study Team
Paediatrics and Reproductive Medicine
Public Health and Health Services
Pediatrics
Clinical sciences
Language
Abstract
BackgroundHuman immunodeficiency virus (HIV)-infected children receiving antiretroviral therapy (ART) have increased prevalence of hyperlipidemia and risk factors for cardiovascular disease. No studies have investigated the efficacy and safety of statins in this population.MethodsHIV-infected youth 10 to